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syndrome coronavirus”Dear Editor,
We thank Dr Wiwanitkit for his interest in our recent
article in which we discussed the important findings and
unanswered questions on the evolving epidemic caused by
the Middle East respiratory syndrome coronavirus (MERS-
CoV).1 Until now, the epidemic has not been completely
controlled despite international collaborations, and fears
of a severe acute respiratory syndrome (SARS)-like large-
scale epidemic continue to mount.2 The total number of
laboratory-confirmed and fatal cases keeps on increasing,
and person-to-person transmission is evident in several
recent outbreaks.1 Furthermore, the definitive natural
reservoirs and possible intermediate animal hosts have not
yet been successfully identified. As pointed out by Dr
Wiwanitkit, an increasing number of novel emerging vi-
ruses have likely originated from animals, especially bats
and birds.3 Asymptomatic shedding, dissemination, and
mixing of different viruses are facilitated by the high
species biodiversity, roosting and migratory behaviors, and
unique adaptive immune system of bats and birds.3 The
identification and segregation of the definitive natural
reservoirs and intermediate animal species from humans
would be important measures to prevent further inter-
species transmission of MERS-CoV from animals to humans.
In addition to establishing the mechanism of trans-
mission of MERS-CoV from animal sources to humans, Dr
Wiwanitkit has proposed a number of important public
health measures against the MERS epidemic. One of the
key strategies is the development of accurate diagnostic
tests for both the acute and convalescent phases of the
infection. Although real-time polymerase chain reaction
might be used in the acute phase of the infection, retro-
spective diagnosis and large-scale serological studies
mainly rely on serological tests. This is especially impor-
tant as mild cases of MERS have been increasinglyDOI of original article: http://dx.doi.org/10.1016/
j.jfma.2013.08.009.
0929-6646/$ - see front matter Copyright ª 2013, Elsevier Taiwan LLC
http://dx.doi.org/10.1016/j.jfma.2013.08.007reported.1 Notably, we found that cross-reactive anti-
bodies against MERS-CoV might be found in convalescent
SARS patients’ sera by both immunofluorescent and
neutralizing antibody tests, possibly related to a signifi-
cant B-cell epitope overlapping the heptad repeat 2 region
of the spike protein.4 Therefore, in Southeast Asia, where
the proportion of the general population with previous
SARS infection might be higher than that in the Middle East
and Europe, this potential diagnostic fallacy should be
considered. Further refinement of serological tests and
other diagnostic tools, and continuous preparedness
against MERS would be important to prevent a SARS-like
epidemic in our region.
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